Unknown

Dataset Information

0

Barriers and facilitators of HPV vaccination in sub-saharan Africa: a systematic review.


ABSTRACT:

Background

Human Papilloma Virus (HPV) is the most common sexually transmitted infection worldwide. Globally, both men and women have a 50% risk of being infected at least once in their life. HPV prevalence is among the highest in sub-Saharan Africa (SSA), at an average of 24%. HPV causes different types of cancers, including cervical cancer (CC), which is the leading cause of cancer deaths among women in SSA. HPV-vaccination has been proven to be effective in reducing HPV induced cancers. SSA countries are delayed in reaching the WHO's target of fully vaccinating 90% of girls within the age of 15 by 2030. Our systematic review aims to identify barriers and facilitators of HPV-vaccination in SSA to inform national implementation strategies in the region.

Methods

This is a mixed method systematic review based on the PRISMA statement and The Joanna Briggs Institute Reviewers' Manual. Search strategies were adapted to each selected database: PubMed/MEDLINE, Livivo, Google Scholar, Science Direct, and African Journals Online for papers published in English, Italian, German, French and Spanish between 1 December 2011 and 31 December 2021. Zotero and Rayyan were the software used for data management. The appraisal was conducted by three independent reviewers.

Results

A total of 20 articles were selected for appraisal from an initial 536 articles. Barriers included: limited health system capacities, socio-economic status, stigma, fear and costs of vaccines, negative experience with vaccinations, COVID-19 pandemic, lack of correct information, health education (HE) and consent. Additionally, we found that boys are scarcely considered for HPV-vaccination by parents and stakeholders. Facilitators included: information and knowledge, policy implementation, positive experience with vaccinations, HE, stakeholders' engagement, women's empowerment, community engagement, seasonality, and target-oriented vaccination campaigns.

Conclusions

This review synthesizes barriers and facilitators of HPV-vaccinations in SSA. Addressing these can contribute to the implementation of more effective HPV immunization programs targeted at eliminating CC in line with the WHO 90/70/90 strategy.

Registration and funding

Protocol ID: CRD42022338609 registered in the International Prospective Register of Systematic Reviews (PROSPERO). Partial funds: German Centre for Infection research (DZIF) project NAMASTE: 8,008,803,819.

SUBMITTER: Kutz JM 

PROVIDER: S-EPMC10214362 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Barriers and facilitators of HPV vaccination in sub-saharan Africa: a systematic review.

Kutz Jean-Marc JM   Rausche Pia P   Gheit Tarik T   Puradiredja Dewi Ismajani DI   Fusco Daniela D  

BMC public health 20230526 1


<h4>Background</h4>Human Papilloma Virus (HPV) is the most common sexually transmitted infection worldwide. Globally, both men and women have a 50% risk of being infected at least once in their life. HPV prevalence is among the highest in sub-Saharan Africa (SSA), at an average of 24%. HPV causes different types of cancers, including cervical cancer (CC), which is the leading cause of cancer deaths among women in SSA. HPV-vaccination has been proven to be effective in reducing HPV induced cancer  ...[more]

Similar Datasets

| S-EPMC7934357 | biostudies-literature
| S-EPMC7189679 | biostudies-literature
| S-EPMC8259208 | biostudies-literature
| S-EPMC7362649 | biostudies-literature
| S-EPMC5378008 | biostudies-literature
| S-EPMC5946543 | biostudies-literature
| S-EPMC9096545 | biostudies-literature
| S-EPMC9611461 | biostudies-literature
| S-EPMC5461715 | biostudies-literature
| S-EPMC11675486 | biostudies-literature